Global Cancer Treatment Drugs Sales Market Report 2017

Published: Sep, 2017 | Pages: 127 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the global Cancer Treatment Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Cancer Treatment Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Cancer Treatment Drugs market competition by top manufacturers/players, with Cancer Treatment Drugs sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche (Switzerland)
    Novartis (Switzerland)
    Celgene (U.S.)
    Amgen (U.S.)
    Johnson & Johnson (U.S.)
    Bristol-Myers Squibb (U.S.)
    Takeda (Japan)
    Eli Lilly (U.S.)
    Pfizer (U.S.)
    AstraZeneca (Sweden)
    Astellas (Japan)
    Sanofi (France)
    Bayer (Germany)
    Merck & Co. (U.S.)
    Biogen Idec (U.S.)
    Kyowa Hakko Kirin (Japan)
    Otsuka (Japan)
    Teva (Israel)
    Eisai (Japan)
    Merck KGaA (Germany)
    Ipsen (France)
    AbbVie (U.S.)
    Gilead Sciences (U.S.)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Chemotherapy
    Targeted Therapy
    Immunotherapy
    Hormonal Therapy (Biologic Therapy)
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cancer Treatment Drugs for each application, including
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Cancer Treatment Drugs Sales Market Report 2017
1 Cancer Treatment Drugs Market Overview
    1.1 Product Overview and Scope of Cancer Treatment Drugs
    1.2 Classification of Cancer Treatment Drugs by Product Category
        1.2.1 Global Cancer Treatment Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Cancer Treatment Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Chemotherapy
        1.2.4 Targeted Therapy
        1.2.5 Immunotherapy
        1.2.6 Hormonal Therapy (Biologic Therapy)
        1.2.7 Others
    1.3 Global Cancer Treatment Drugs Market by Application/End Users
        1.3.1 Global Cancer Treatment Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Other Cancers
    1.4 Global Cancer Treatment Drugs Market by Region
        1.4.1 Global Cancer Treatment Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Cancer Treatment Drugs Status and Prospect (2012-2022)
        1.4.3 China Cancer Treatment Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Cancer Treatment Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Cancer Treatment Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Cancer Treatment Drugs Status and Prospect (2012-2022)
        1.4.7 India Cancer Treatment Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Cancer Treatment Drugs (2012-2022)
        1.5.1 Global Cancer Treatment Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)

2 Global Cancer Treatment Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Cancer Treatment Drugs Market Competition by Players/Suppliers
        2.1.1 Global Cancer Treatment Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Cancer Treatment Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Cancer Treatment Drugs (Volume and Value) by Type
        2.2.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Cancer Treatment Drugs (Volume and Value) by Region
        2.3.1 Global Cancer Treatment Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Cancer Treatment Drugs (Volume) by Application

3 United States Cancer Treatment Drugs (Volume, Value and Sales Price)
    3.1 United States Cancer Treatment Drugs Sales and Value (2012-2017)
        3.1.1 United States Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Cancer Treatment Drugs Sales Price Trend (2012-2017)
    3.2 United States Cancer Treatment Drugs Sales Volume and Market Share by Players
    3.3 United States Cancer Treatment Drugs Sales Volume and Market Share by Type
    3.4 United States Cancer Treatment Drugs Sales Volume and Market Share by Application

4 China Cancer Treatment Drugs (Volume, Value and Sales Price)
    4.1 China Cancer Treatment Drugs Sales and Value (2012-2017)
        4.1.1 China Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Cancer Treatment Drugs Sales Price Trend (2012-2017)
    4.2 China Cancer Treatment Drugs Sales Volume and Market Share by Players
    4.3 China Cancer Treatment Drugs Sales Volume and Market Share by Type
    4.4 China Cancer Treatment Drugs Sales Volume and Market Share by Application

5 Europe Cancer Treatment Drugs (Volume, Value and Sales Price)
    5.1 Europe Cancer Treatment Drugs Sales and Value (2012-2017)
        5.1.1 Europe Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Cancer Treatment Drugs Sales Price Trend (2012-2017)
    5.2 Europe Cancer Treatment Drugs Sales Volume and Market Share by Players
    5.3 Europe Cancer Treatment Drugs Sales Volume and Market Share by Type
    5.4 Europe Cancer Treatment Drugs Sales Volume and Market Share by Application

6 Japan Cancer Treatment Drugs (Volume, Value and Sales Price)
    6.1 Japan Cancer Treatment Drugs Sales and Value (2012-2017)
        6.1.1 Japan Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Cancer Treatment Drugs Sales Price Trend (2012-2017)
    6.2 Japan Cancer Treatment Drugs Sales Volume and Market Share by Players
    6.3 Japan Cancer Treatment Drugs Sales Volume and Market Share by Type
    6.4 Japan Cancer Treatment Drugs Sales Volume and Market Share by Application

7 Southeast Asia Cancer Treatment Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Cancer Treatment Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Cancer Treatment Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Application

8 India Cancer Treatment Drugs (Volume, Value and Sales Price)
    8.1 India Cancer Treatment Drugs Sales and Value (2012-2017)
        8.1.1 India Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Cancer Treatment Drugs Sales Price Trend (2012-2017)
    8.2 India Cancer Treatment Drugs Sales Volume and Market Share by Players
    8.3 India Cancer Treatment Drugs Sales Volume and Market Share by Type
    8.4 India Cancer Treatment Drugs Sales Volume and Market Share by Application

9 Global Cancer Treatment Drugs Players/Suppliers Profiles and Sales Data
    9.1 Roche (Switzerland)
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Roche (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Novartis (Switzerland)
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Novartis (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Celgene (U.S.)
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Celgene (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Amgen (U.S.)
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Amgen (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Johnson & Johnson (U.S.)
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Bristol-Myers Squibb (U.S.)
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Takeda (Japan)
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Takeda (Japan) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Eli Lilly (U.S.)
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Eli Lilly (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Pfizer (U.S.)
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Pfizer (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 AstraZeneca (Sweden)
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Cancer Treatment Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 AstraZeneca (Sweden) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Astellas (Japan)
    9.12 Sanofi (France)
    9.13 Bayer (Germany)
    9.14 Merck & Co. (U.S.)
    9.15 Biogen Idec (U.S.)
    9.16 Kyowa Hakko Kirin (Japan)
    9.17 Otsuka (Japan)
    9.18 Teva (Israel)
    9.19 Eisai (Japan)
    9.20 Merck KGaA (Germany)
    9.21 Ipsen (France)
    9.22 AbbVie (U.S.)
    9.23 Gilead Sciences (U.S.)

10 Cancer Treatment Drugs Maufacturing Cost Analysis
    10.1 Cancer Treatment Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Cancer Treatment Drugs
    10.3 Manufacturing Process Analysis of Cancer Treatment Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Cancer Treatment Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Cancer Treatment Drugs Market Forecast (2017-2022)
    14.1 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Cancer Treatment Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Cancer Treatment Drugs Price Forecast by Type (2017-2022)
    14.4 Global Cancer Treatment Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Cancer Treatment Drugs
    Figure Global Cancer Treatment Drugs Sales Volume Comparison (K MT) by Type (2012-2022)
    Figure Global Cancer Treatment Drugs Sales Volume Market Share by Type (Product Category) in 2016
    Figure Chemotherapy Product Picture
    Figure Targeted Therapy Product Picture
    Figure Immunotherapy Product Picture
    Figure Hormonal Therapy (Biologic Therapy) Product Picture
    Figure Others Product Picture
    Figure Global Cancer Treatment Drugs Sales Comparison (K MT) by Application (2012-2022)
    Figure Global Sales Market Share of Cancer Treatment Drugs by Application in 2016
    Figure Blood Cancer Examples
    Table Key Downstream Customer in Blood Cancer
    Figure Breast Cancer Examples
    Table Key Downstream Customer in Breast Cancer
    Figure Gastrointestinal Cancer Examples
    Table Key Downstream Customer in Gastrointestinal Cancer
    Figure Prostate Cancer Examples
    Table Key Downstream Customer in Prostate Cancer
    Figure Respiratory/Lung Cancer Examples
    Table Key Downstream Customer in Respiratory/Lung Cancer
    Figure Other Cancers Examples
    Table Key Downstream Customer in Other Cancers
    Figure Global Cancer Treatment Drugs Market Size (Million USD) by Regions (2012-2022)
    Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate (2012-2022)
    Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Market Major Players Cancer Treatment Drugs Sales Volume (K MT) (2012-2017)
    Table Global Cancer Treatment Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
    Table Global Cancer Treatment Drugs Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Cancer Treatment Drugs Sales Share by Players/Suppliers
    Figure 2017 Cancer Treatment Drugs Sales Share by Players/Suppliers
    Figure Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global Cancer Treatment Drugs Revenue Share by Players/Suppliers (2012-2017)
    Table 2016 Global Cancer Treatment Drugs Revenue Share by Players
    Table 2017 Global Cancer Treatment Drugs Revenue Share by Players
    Table Global Cancer Treatment Drugs Sales (K MT) and Market Share by Type (2012-2017)
    Table Global Cancer Treatment Drugs Sales Share (K MT) by Type (2012-2017)
    Figure Sales Market Share of Cancer Treatment Drugs by Type (2012-2017)
    Figure Global Cancer Treatment Drugs Sales Growth Rate by Type (2012-2017)
    Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Global Cancer Treatment Drugs Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Cancer Treatment Drugs by Type (2012-2017)
    Figure Global Cancer Treatment Drugs Revenue Growth Rate by Type (2012-2017)
    Table Global Cancer Treatment Drugs Sales Volume (K MT) and Market Share by Region (2012-2017)
    Table Global Cancer Treatment Drugs Sales Share by Region (2012-2017)
    Figure Sales Market Share of Cancer Treatment Drugs by Region (2012-2017)
    Figure Global Cancer Treatment Drugs Sales Growth Rate by Region in 2016
    Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Cancer Treatment Drugs by Region (2012-2017)
    Figure Global Cancer Treatment Drugs Revenue Growth Rate by Region in 2016
    Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Cancer Treatment Drugs by Region (2012-2017)
    Figure Global Cancer Treatment Drugs Revenue Market Share by Region in 2016
    Table Global Cancer Treatment Drugs Sales Volume (K MT) and Market Share by Application (2012-2017)
    Table Global Cancer Treatment Drugs Sales Share (%) by Application (2012-2017)
    Figure Sales Market Share of Cancer Treatment Drugs by Application (2012-2017)
    Figure Global Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Figure United States Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table United States Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table United States Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure United States Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table United States Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table United States Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure United States Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table United States Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table United States Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure United States Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Figure China Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table China Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table China Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure China Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table China Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table China Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure China Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table China Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table China Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure China Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Figure Europe Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table Europe Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table Europe Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table Europe Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Figure Japan Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Figure India Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)
    Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)
    Table India Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)
    Table India Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)
    Figure India Cancer Treatment Drugs Sales Volume Market Share by Players in 2016
    Table India Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)
    Table India Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)
    Figure India Cancer Treatment Drugs Sales Volume Market Share by Type in 2016
    Table India Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)
    Table India Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)
    Figure India Cancer Treatment Drugs Sales Volume Market Share by Application in 2016
    Table Roche (Switzerland) Basic Information List
    Table Roche (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Roche (Switzerland) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Roche (Switzerland) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Roche (Switzerland) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Novartis (Switzerland) Basic Information List
    Table Novartis (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Novartis (Switzerland) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Novartis (Switzerland) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Novartis (Switzerland) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Celgene (U.S.) Basic Information List
    Table Celgene (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Celgene (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Celgene (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Celgene (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Amgen (U.S.) Basic Information List
    Table Amgen (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Amgen (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Amgen (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Amgen (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Johnson & Johnson (U.S.) Basic Information List
    Table Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Bristol-Myers Squibb (U.S.) Basic Information List
    Table Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Takeda (Japan) Basic Information List
    Table Takeda (Japan) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Takeda (Japan) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Takeda (Japan) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Takeda (Japan) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Eli Lilly (U.S.) Basic Information List
    Table Eli Lilly (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Eli Lilly (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Pfizer (U.S.) Basic Information List
    Table Pfizer (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Pfizer (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure Pfizer (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure Pfizer (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table AstraZeneca (Sweden) Basic Information List
    Table AstraZeneca (Sweden) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales Growth Rate (2012-2017)
    Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales Global Market Share (2012-2017
    Figure AstraZeneca (Sweden) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)
    Table Astellas (Japan) Basic Information List
    Table Sanofi (France) Basic Information List
    Table Bayer (Germany) Basic Information List
    Table Merck & Co. (U.S.) Basic Information List
    Table Biogen Idec (U.S.) Basic Information List
    Table Kyowa Hakko Kirin (Japan) Basic Information List
    Table Otsuka (Japan) Basic Information List
    Table Teva (Israel) Basic Information List
    Table Eisai (Japan) Basic Information List
    Table Merck KGaA (Germany) Basic Information List
    Table Ipsen (France) Basic Information List
    Table AbbVie (U.S.) Basic Information List
    Table Gilead Sciences (U.S.) Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Cancer Treatment Drugs
    Figure Manufacturing Process Analysis of Cancer Treatment Drugs
    Figure Cancer Treatment Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Cancer Treatment Drugs Major Players in 2016
    Table Major Buyers of Cancer Treatment Drugs
    Table Distributors/Traders List
    Figure Global Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Cancer Treatment Drugs Price (USD/MT) and Trend Forecast (2017-2022)
    Table Global Cancer Treatment Drugs Sales Volume (K MT) Forecast by Regions (2017-2022)
    Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
    Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions in 2022
    Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
    Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2017-2022)
    Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions in 2022
    Figure United States Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure China Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure China Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
    Figure Europe Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Global Cancer Treatment Drugs Sales (K MT) Forecast by Type (2017-2022)
    Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Type (2017-2022)
    Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2017-2022)
    Table Global Cancer Treatment Drugs Price (USD/MT) Forecast by Type (2017-2022)
    Table Global Cancer Treatment Drugs Sales (K MT) Forecast by Application (2017-2022)
    Figure Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.